| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.053 | 0.4 |